Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infanrix Hexa and Prevenar in pediatric HSCT
NCT00169728Phase 3Completed
- Sponsor
- Heinrich Heine University Düsseldorf
- Start
- Sep 2003
- Primary completion
- Jun 2006
- Modality
- Recombinant Proteins and Enzymes, Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of pertussis filamentous haemagglutinin, pneumococcal 7-valent conjugate vaccine in diphtheria, Tetanus, pertussis, hepatitis B (HBV), poliomyelitis, sponsored by Heinrich Heine University Düsseldorf. Started Sep 2003; status: completed.
02
Drugs
pertussis filamentous haemagglutininpneumococcal 7-valent conjugate vaccine
03
Conditions
diphtheriaTetanuspertussishepatitis B (HBV)poliomyelitis
Beyond the preview
Go deeper on NCT00169728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00169728.